Literature DB >> 16480340

Control of cell migration: a tumour suppressor function for p53?

Lauréline Roger1, Gilles Gadea, Pierre Roux.   

Abstract

Much remains to be learned about how cancer cells acquire the property of migration, a prerequisite for invasiveness and metastasis. Loss of p53 functions is assumed to be a crucial step in the development of many types of cancers, leading to dysregulation of cell cycle checkpoint controls and apoptosis. However, emerging evidence shows that the contribution of the tumour suppressor p53 to the control of tumorigenesis is not restricted to its well-known anti-proliferative activities, but is extended to other stages of cancer development, i.e. the modulation of cell migration. This interesting alternative function has been proposed in light of the effect of p53 on specific features of migrating cells, including cell spreading, establishment of cell polarization and the production of protrusions. The effects of p53 on cell motility are largely mediated through the regulation of Rho signalling, thereby controlling actin cytoskeletal organization. These recent studies connect the regulation of proliferation to the control of cell migration and define a new concept of p53 function as a tumour suppressor gene, suggesting that p53 might be involved in tumour invasion and metastasis. This review focuses on emerging data concerning the properties of p53 that contribute to its atypical role in the regulation of cell migration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16480340     DOI: 10.1042/BC20050058

Source DB:  PubMed          Journal:  Biol Cell        ISSN: 0248-4900            Impact factor:   4.458


  57 in total

1.  Characterization and optimization of a novel protein-protein interaction biosensor high-content screening assay to identify disruptors of the interactions between p53 and hDM2.

Authors:  Drew D Dudgeon; Sunita N Shinde; Tong Ying Shun; John S Lazo; Christopher J Strock; Kenneth A Giuliano; D Lansing Taylor; Patricia A Johnston; Paul A Johnston
Journal:  Assay Drug Dev Technol       Date:  2010-08       Impact factor: 1.738

Review 2.  p53 regulation of podosome formation and cellular invasion in vascular smooth muscle cells.

Authors:  Alan S Mak
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

3.  Cardiac outflow tract septation failure in Pax3-deficient embryos is due to p53-dependent regulation of migrating cardiac neural crest.

Authors:  Sarah C Morgan; Hyung-Yul Lee; Frédéric Relaix; Lisa L Sandell; John M Levorse; Mary R Loeken
Journal:  Mech Dev       Date:  2008-07-13       Impact factor: 1.882

4.  A transcription co-factor integrates cell adhesion and motility with the p53 response.

Authors:  Amanda S Coutts; Louise Weston; Nicholas B La Thangue
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

5.  AP4 activates cell migration and EMT mediated by p53 in MDA-MB-231 breast carcinoma cells.

Authors:  Shaopeng Chen; Sung-Kay Chiu
Journal:  Mol Cell Biochem       Date:  2015-06-03       Impact factor: 3.396

6.  Bridged Analogues for p53-Dependent Cancer Therapy Obtained by S-Alkylation.

Authors:  Ewa D Micewicz; Shantanu Sharma; Alan J Waring; Hai T Luong; William H McBride; Piotr Ruchala
Journal:  Int J Pept Res Ther       Date:  2015-08-19       Impact factor: 1.931

7.  Transcriptional repression of epithelial cell adhesion molecule contributes to p53 control of breast cancer invasion.

Authors:  Narendra V Sankpal; Michael W Willman; Timothy P Fleming; John D Mayfield; William E Gillanders
Journal:  Cancer Res       Date:  2009-01-13       Impact factor: 12.701

Review 8.  The expanding universe of p53 targets.

Authors:  Daniel Menendez; Alberto Inga; Michael A Resnick
Journal:  Nat Rev Cancer       Date:  2009-10       Impact factor: 60.716

9.  The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound.

Authors:  Yari Ciribilli; Virginia Andreotti; Daniel Menendez; Jan-Stephan Langen; Gilbert Schoenfelder; Michael A Resnick; Alberto Inga
Journal:  PLoS One       Date:  2010-04-21       Impact factor: 3.240

10.  ALDH1L1 inhibits cell motility via dephosphorylation of cofilin by PP1 and PP2A.

Authors:  N V Oleinik; N I Krupenko; S A Krupenko
Journal:  Oncogene       Date:  2010-08-23       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.